130 related articles for article (PubMed ID: 17575010)
1. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin.
Laudi S; Trump S; Schmitz V; West J; McMurtry IF; Mutlak H; Christians U; Weimann J; Kaisers U; Steudel W
Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L630-8. PubMed ID: 17575010
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study.
McMurtry MS; Bonnet S; Michelakis ED; Bonnet S; Haromy A; Archer SL
Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L933-40. PubMed ID: 17675370
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
Ozturk EI; Uma S
J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
[TBL] [Abstract][Full Text] [Related]
5. Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats.
Xie L; Lin P; Xie H; Xu C
Clin Exp Hypertens; 2010; 32(8):547-54. PubMed ID: 21091363
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
8. The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats.
Gao YF; Zhu XD; Shi DM; Jing ZC; Li L; Ma D; Fan ZX; Li J; Wang YW; Wu BX
Int J Mol Med; 2010 Oct; 26(4):541-7. PubMed ID: 20818494
[TBL] [Abstract][Full Text] [Related]
9. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension.
Meghwani H; Prabhakar P; Mohammed SA; Seth S; Hote MP; Banerjee SK; Arava S; Ray R; Maulik SK
J Ethnopharmacol; 2017 Feb; 197():184-194. PubMed ID: 27401289
[TBL] [Abstract][Full Text] [Related]
13. Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.
Jiang X; Yuan L; Li P; Wang J; Wang P; Zhang L; Sun B; Sun W
Cell Physiol Biochem; 2015; 37(5):1712-24. PubMed ID: 26544069
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
Guignabert C; Raffestin B; Benferhat R; Raoul W; Zadigue P; Rideau D; Hamon M; Adnot S; Eddahibi S
Circulation; 2005 May; 111(21):2812-9. PubMed ID: 15927991
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the serotonin pathway as a therapeutic target for pulmonary hypertension.
Gray EA; Tsuchimochi H; Pearson JT; Sonobe T; Fujii Y; Yoshimoto M; Umetani K; Shirai M; Schwenke DO
J Synchrotron Radiat; 2013 Sep; 20(Pt 5):756-64. PubMed ID: 23955040
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.
Liu B; Wang XQ; Yu L; Zhou TF; Wang XM; Liu HM
Exp Lung Res; 2009 Jun; 35(5):411-26. PubMed ID: 19842842
[TBL] [Abstract][Full Text] [Related]
17. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
19. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
Suzuki R; Maehara R; Kobuchi S; Tanaka R; Ohkita M; Matsumura Y
Life Sci; 2012 Oct; 91(13-14):693-8. PubMed ID: 22542556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]